New blood test may spot kidney danger in liver patients
NCT ID NCT07452484
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a simple blood test called the Systemic Immune Inflammation Index (SII) can help diagnose and predict acute kidney injury (AKI) in people with liver cirrhosis. AKI is a common and serious complication in cirrhosis, but current tests are often unreliable. The study will follow 100 hospitalized cirrhosis patients, measuring SII over time to see if it detects kidney problems earlier and helps tell apart different causes. If it works, this cheap and widely available test could improve care for a high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a simple, cheap blood test to detect kidney injury earlier in cirrhosis patients, improving treatment timing.
- What could go wrong
- This is a small, early-stage study (100 participants) that has not yet started. The SII test may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AKI IN CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.